Trials / Completed
CompletedNCT03403933
Vitamin D Supplementation on in Major Orthopedic Surgery
Study of the Effect of Calcifediol Supplementation on Left Ventricular Function in Cardiopathic Patients Undergoing Major Orthopedic Surgery
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 74 (actual)
- Sponsor
- I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio · Academic / Other
- Sex
- All
- Age
- 55 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
Prospective, monocentric study in open, aimed at evaluating the effects of supplementation with calcifediol on left ventricular function parameters in cardiopathic subjects undergoing major orthopedic surgery.
Detailed description
Population of the study: 47 cardiopathic patients with hypovitaminosis D supplemented with calcifediol to reach vitamin D levels\> 30 ng / ml within 6 months. The purpose of this study is to evaluate the improvement of the ejection fraction or GLS (global longitudinal strain) calculated by speckle tracking at 6 months in cardiopathic patients with vitamin D deficiency during functional recovery after major orthopedic surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Didrogyl | Calcifediol will be administered at a dose of 10 drops per day (as indicated for use) for 6 months or until vitamin D levels\> 30 ng / ml are obtained. Once these values have been obtained, the dosage can be reduced to a dosage of 4/5 drops of calcifediol (1 drop contains 5mcg of calcifediol) with the aim to maintain the plasma values of 25 (OH) D in a optimal range between 30-60 ng / ml during the 6 month of the duration of the study. |
Timeline
- Start date
- 2017-01-16
- Primary completion
- 2017-09-23
- Completion
- 2018-07-16
- First posted
- 2018-01-19
- Last updated
- 2023-05-09
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT03403933. Inclusion in this directory is not an endorsement.